Pharmacoepidemiology /

Pharmacoepidemiology /

Saved in:
Bibliographic Details
Edition:4th ed.
Imprint:Chichester ; Hoboken, NJ : J. Wiley, c2005.
Description:xvii, 889 p. : ill. ; 25 cm.
Language:English
Subject:
Pharmacoepidemiology.
Pharmacology.
Pharmacoepidemiology -- methods.
Pharmacoepidemiology.
Pharmacology.
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/5818979
Hidden Bibliographic Details
Other authors / contributors:Strom, Brian L.
ISBN:0470866810 (alk. paper)
Notes:Includes bibliographical references and index.

MARC

LEADER 00000pam a22000004a 4500
001 5818979
003 ICU
005 20061108123500.0
008 050412s2005 enka b 001 0 eng
010 |a  2005047360 
020 |a 0470866810 (alk. paper) 
040 |a DNLM/DLC  |c DLC  |d DLC  |d UtOrBLW  |d OrLoB-B 
042 |a pcc 
050 0 0 |a RM302.5  |b .P53 2005 
060 1 0 |a QZ 42  |b P536 2005 
082 0 0 |a 615/.7042  |2 22 
245 0 0 |a Pharmacoepidemiology /  |c edited by Brian L. Strom. 
250 |a 4th ed. 
260 |a Chichester ;  |a Hoboken, NJ :  |b J. Wiley,  |c c2005. 
300 |a xvii, 889 p. :  |b ill. ;  |c 25 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
504 |a Includes bibliographical references and index. 
505 0 0 |g 1.  |t What is pharmacoepidemiology? /  |r Brian L. Strom --  |g 2.  |t Study designs available for pharmacoepidemiology studies /  |r Brian L. Strom --  |g 3.  |t Sample size considerations for pharmacopidemiology studies /  |r Brian L. Strom --  |g 4.  |t Basic principles of clinical pharmacology relevant to pharmacoepidemiology studies /  |r David A. Henry, Patricia McGettigan, Anne Tonkin and Sean Hennessy --  |g 5.  |t When should one perform pharmacoepidemiology studies? /  |r Brian L. Strom --  |g 6.  |t A view from academia /  |r Robert M. Califf and Leanne K. Madre --  |g 7.  |t A view from industry /  |r Robert F. Reynolds, Dale B. Glasser and Gretchen S. Dieck --  |g 8.  |t A view from regulatory agencies /  |r Peter Arlett, Jane Moseley and Paul J. Seligman --  |g 9.  |t Spontaneous reporting in the United States /  |r Syed Rizwanuddin Ahmad, Roger A. Goetsch and Norman S. Marks --  |g 10.  |t Global drug surveillance : the WHO programme for international drug monitoring /  |r I. Ralph Edwards, Sten Olsson, Marie Lindquist and Bruce Hugman --  |g 11.  |t Case-control surveillance /  |r Lynn Rosenberg, Patricia F. Coogan and Julie R. Palmer --  |g 12.  |t Prescription-event monitoring /  |r Saad A. W. Shakir --  |g 13.  |t Overview of automated databases in pharmacoepidemiology /  |r Brian L. Strom --  |g 14.  |t Group health cooperative /  |r Kathleen W. Saunders, Robert L. Davis and Andy Stergachis --  |g 15.  |t Kaiser Permanente medical case program /  |r Joe V. Selby, David H. Smith, Eric S. Johnson, Marsha A. Raebel, Gary D. Friedman and Bentson H. McFarland --  |g 16.  |t The HMO research network /  |r K. Arnold Chan, Robert L. Davis, Margaret J. Gunter, Jerry H. Gurwitz, Lisa J. Herrinton, Winnie W. Nelson, Marsha A. Raebel, Douglas W. Roblin, David H. Smith and Richard Platt --  |g 17.  |t UnitedHealth Group /  |r Deborah Shatin, Nigel S. B. Rawson and Andy Stergachis --  |g 18.  |t Medicaid databases /  |r Sean Hennessy, Jeffrey L. Carson, Wayne A. Ray and Brian L. Strom --  |g 19.  |t Health services databases in Saskatchewan /  |r Winanne Downey, MaryRose Stang, Patricia Beck, William Osei and James L. Nichol --  |g 20.  |t Automated pharmacy record linkage in the Netherlands /  |r Hubert G. Leufkens and John Urquhart --  |g 21.  |t The Tayside medicines monitoring unit (MEMO) /  |r Li Wei, John Parkinson and Thomas M. MacDonald --  |g 22.  |t The UK general practice research database /  |r Joel M. Gelfand, David J. Margolis and Hassy Dattani --  |g 23.  |t Other approaches to pharmacoepidemiology studies /  |r Brian L. Strom --  |g 24.  |t How should one perform pharmacoepidemiology studies? : choosing among the available alternatives /  |r Brian L. Strom --  |g 25.  |t National medicinal drug policies : their relationship to pharmacoepidemiology /  |r Suzanne Hill and David A. Henry --  |g 26.  |t Premarketing applications of pharmacoepidemiology /  |r Harry A. Guess --  |g 27.  |t Studies of drug utilization /  |r David Lee and Ulf Bergman --  |g 28.  |t Evaluating and improving physician prescribing /  |r Sumit R. Majumdar, Helene Levens Lipton and Stephen B. Soumerai --  |g 29.  |t Drug utilization review /  |r Sean Hennessy, Stephen B. Soumerai, Helene Levens Lipton and Brian L. Strom --  |g 30.  |t Special methodological issues in pharmacoepidemiology studies of vaccine safety /  |r Robert T. Chen, Robert L. Davis and Philip H. Rhodes --  |g 31.  |t Pharmacoepidemiologic studies of devices /  |r Roselie A. Bright --  |g 32.  |t Studies of drug-induced birth defects /  |r Allen A. Mitchell --  |g 33.  |t Pharmacoepidemiology and risk management /  |r David J. Graham, Andrew D. Mosholder, Kate Gelperin and Mark I. Avigan --  |g 34.  |t The use of pharmacoepidemiology to study medication errors /  |r Rainu Kaushal and David W. Bates --  |g 35.  |t Hospital pharmacoepidemiology /  |r Brian L. Strom and Ritu Schinnar --  |g 36.  |t Determining causation from case reports /  |r Judith K. Jones --  |g 37.  |t Molecular pharmacoepidemiology /  |r Stephen E. Kimmel, Hubert G. Leujkens and Timothy R. Rehbeck --  |g 38.  |t Biothical issues in pharmacoepidemiologic research /  |r David Casarett, Jason Karlawish, Elizabeth Andrews and Arthur Caplan --  |g 39.  |t The use of randomized controlled trials for pharmacoepidemiology studies /  |r Samuel M. Lesko and Allen M. Mitchell --  |g 40.  |t The use of pharmacoepidemiology to study beneficial drug effects /  |r Brian L. Strom and Kenneth L. Melmon --  |g 41.  |t Pharmacoeconomics : economic evaluation of pharmaceuticals /  |r Kevin A. Schulman, Henry A. Glick and Daniel Polsky --  |g 42.  |t Using quality-of-life measurements in pharmacoepidemiologic research /  |r Holger Schunemann, Gordon H. Guyatt and Roman Joeschke --  |g 43.  |t N-of-1 randomized clinical trials in pharmacoepidemiology /  |r Gordon H. Guyatt, Roman Jaeschke and Robin Roberts --  |g 44.  |t The use of meta-analysis in pharmacoepidemiology /  |r Jesse A. Berlin and Carin J. Kim --  |g 45.  |t Validity of pharmacoepidemiologic drug and diagnosis data /  |r Suzanne I. West, Brian I. Strom and Charles Poole --  |g 46.  |t Variable compliance and persistence with prescribed drug dosing regimens : implications for benefits, risk, and economics of pharmacotherapy /  |r John Urquhart --  |g 47.  |t Bias and confounding in pharmacoepidemiology /  |r Ilona Csizmadi, Jean-Paul Collet and Jean-Francois Boivin --  |g 48.  |t Novel approaches to pharmacoepidemiology study design and statistical analysis /  |r Samy Suissa --  |g 49.  |t The future of pharmacoepidemiology /  |r Brian L. Strom and Sean Hennessy. 
650 0 |a Pharmacoepidemiology.  |0 http://id.loc.gov/authorities/subjects/sh89004031 
650 0 |a Pharmacology.  |0 http://id.loc.gov/authorities/subjects/sh85100599 
650 1 2 |a Pharmacoepidemiology  |x methods. 
650 7 |a Pharmacoepidemiology.  |2 fast  |0 http://id.worldcat.org/fast/fst01060242 
650 7 |a Pharmacology.  |2 fast  |0 http://id.worldcat.org/fast/fst01060259 
700 1 |a Strom, Brian L.  |0 http://id.loc.gov/authorities/names/n88088423  |1 http://viaf.org/viaf/41996111 
901 |a ToCBNA 
903 |a HeVa 
903 |a Hathi 
035 |a (OCoLC)59279735 
929 |a cat 
999 f f |i 0ff1bd87-259b-5e88-9abc-0fdaa319f308  |s 8563151b-4b75-581a-b3cd-437bac46e1d6 
928 |t Library of Congress classification  |a RM302.5 .P53 2005  |l JCL  |c JCL-Sci  |i 4991453 
927 |t Library of Congress classification  |a RM302.5 .P53 2005  |l JCL  |c JCL-Sci  |e CRERAR  |b 75024536  |i 7953733 
The John Crerar Library bookplate

Similar Items